JP2013531801A5 - - Google Patents

Download PDF

Info

Publication number
JP2013531801A5
JP2013531801A5 JP2013518768A JP2013518768A JP2013531801A5 JP 2013531801 A5 JP2013531801 A5 JP 2013531801A5 JP 2013518768 A JP2013518768 A JP 2013518768A JP 2013518768 A JP2013518768 A JP 2013518768A JP 2013531801 A5 JP2013531801 A5 JP 2013531801A5
Authority
JP
Japan
Prior art keywords
hapten
peroxidase
sample
conjugate
subsequent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013518768A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013531801A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/042849 external-priority patent/WO2012003476A2/en
Publication of JP2013531801A publication Critical patent/JP2013531801A/ja
Publication of JP2013531801A5 publication Critical patent/JP2013531801A5/ja
Pending legal-status Critical Current

Links

JP2013518768A 2010-07-02 2011-07-01 標的検出のためのハプテンコンジュゲート Pending JP2013531801A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US39894610P 2010-07-02 2010-07-02
US61/398,946 2010-07-02
US201161464216P 2011-02-28 2011-02-28
US61/464,216 2011-02-28
PCT/US2011/042849 WO2012003476A2 (en) 2010-07-02 2011-07-01 Hapten conjugates for target detection

Publications (2)

Publication Number Publication Date
JP2013531801A JP2013531801A (ja) 2013-08-08
JP2013531801A5 true JP2013531801A5 (cg-RX-API-DMAC7.html) 2014-07-17

Family

ID=44583735

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013518768A Pending JP2013531801A (ja) 2010-07-02 2011-07-01 標的検出のためのハプテンコンジュゲート

Country Status (6)

Country Link
US (1) US20130109019A1 (cg-RX-API-DMAC7.html)
EP (1) EP2588443A2 (cg-RX-API-DMAC7.html)
JP (1) JP2013531801A (cg-RX-API-DMAC7.html)
AU (1) AU2011274369A1 (cg-RX-API-DMAC7.html)
CA (1) CA2800936A1 (cg-RX-API-DMAC7.html)
WO (1) WO2012003476A2 (cg-RX-API-DMAC7.html)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2542883B1 (en) 2010-03-04 2019-10-02 Ventana Medical Systems, Inc. Processing system for processing specimens using acoustic energy
US10126216B2 (en) 2011-02-17 2018-11-13 Ventana Medical Systems, Inc. Method for tissue sample fixation
US10539487B2 (en) 2010-03-04 2020-01-21 Ventana Medical Systems, Inc. Systems and methods for monitoring tissue sample processing
US9291597B2 (en) 2010-07-02 2016-03-22 Ventana Medical Systems, Inc. Detecting targets using mass tags and mass spectrometry
CA2867144C (en) * 2012-03-27 2019-07-02 Ventana Medical Systems, Inc. Signaling conjugates and methods of use
WO2013167387A1 (en) 2012-05-10 2013-11-14 Ventana Medical Systems, Inc. Uniquely specific probes for pten, pik3ca, met, top2a, and mdm2
WO2014048942A1 (en) 2012-09-25 2014-04-03 Ventana Medical Systems, Inc. Probes for pten, pik3ca, met, and top2a, and method for using the probes
CA2900842C (en) 2013-03-12 2020-01-21 Ventana Medical Systems, Inc. Digitally enhanced microscopy for multiplexed histology
AU2014230945B2 (en) * 2013-03-12 2019-07-11 Ventana Medical Systems, Inc. Proximity assay for in situ detection of targets
WO2014140219A1 (en) * 2013-03-15 2014-09-18 Ventana Medical Systems, Inc. Spectral unmixing
MY197809A (en) 2013-03-15 2023-07-18 Genentech Inc Biomarkers and methods of treating pd-1 and pd-l1 related conditions
WO2014182528A2 (en) 2013-04-30 2014-11-13 California Institute Of Technology Multiplex labeling of molecules by sequential hybridization barcoding
DK3063291T3 (da) * 2013-10-11 2019-05-06 Ventana Med Syst Inc Multiplex her2 og østrogenreceptor co-farvnings-assays til påvisning af tumorheterogenitet
EP3617322A1 (en) 2014-02-24 2020-03-04 Ventana Medical Systems, Inc. Automated rna detection using labeled 2 -o-methyl rna oligonucleotide probes and signal amplification systems
ES2753360T3 (es) 2014-05-29 2020-04-08 Spring Bioscience Corp Anticuerpos contra PD-L1 y usos de los mismos
US20160009805A1 (en) 2014-07-11 2016-01-14 Genentech, Inc. Anti-pd-l1 antibodies and diagnostic uses thereof
EP3254110B1 (en) 2015-02-03 2020-03-18 Ventana Medical Systems, Inc. Histochemical assay for evaluating expression of programmed death ligand 1 (pd-l1)
JP6720138B2 (ja) * 2015-03-13 2020-07-08 シスメックス株式会社 被検物質の検出方法およびその方法に用いられる試薬キット
BR112018009071B1 (pt) 2015-11-06 2021-12-14 Ventana Medical Systems, Inc Método in vitro para preparar uma amostra representativa para análise
JP6832930B2 (ja) * 2015-11-22 2021-02-24 ヴェンタナ メディカル システムズ, インク. Pd−l1陽性腫瘍組織における免疫細胞を同定する方法
JP6876062B2 (ja) 2016-01-26 2021-05-26 ヴェンタナ メディカル システムズ, インク. 自動ダイセクション、次世代シークエンシング、及び自動スライド染色装置を用いる、腫瘍のための予測診断ワークフロー
AU2017229370B2 (en) 2016-03-08 2021-03-11 Ventana Medical Systems, Inc. Multiplexed immunohistochemistry using recombinant antibodies with epitope tags
JP6736921B2 (ja) * 2016-03-10 2020-08-05 コニカミノルタ株式会社 Fish染色方法
EP3441761A4 (en) * 2016-04-06 2019-04-10 Konica Minolta, Inc. FLUORESZENZIMMUNFÄRBEVERFAHREN
WO2018002015A1 (en) * 2016-06-28 2018-01-04 Ventana Medical Systems, Inc. New colors for chromogenic ihc and ish staining with multi-dye quinone methide and tyramide conjugates
CN110073218A (zh) 2016-09-23 2019-07-30 文塔纳医疗系统公司 用于对肿瘤样品中的细胞外基质生物标志物评分的方法和系统
WO2018118786A1 (en) * 2016-12-19 2018-06-28 Ventana Medical Systems, Inc. Methods and systems for quantitative immunohistochemistry
EP3659110A1 (en) 2017-07-24 2020-06-03 Ventana Medical Systems, Inc. Methods and systems for evaluation of immune cell infiltrate in tumor samples
CN111656179B (zh) 2017-11-13 2023-11-03 豪夫迈·罗氏有限公司 用于使用表位电泳进行样品分析的装置
DK3746790T3 (da) 2018-01-31 2023-12-11 Ventana Med Syst Inc Fremgangsmåder og systemer til evaluering af immuncelleinfiltrat i kolorektal stadie III cancer
EP3797296B1 (en) 2018-05-21 2024-09-04 Genentech, Inc. Her2 heterogeneity as a biomarker in cancer
CN108918896A (zh) * 2018-05-29 2018-11-30 郑州左安检测科技有限公司 一种检测苯二氮卓的fitc试纸条及其制备方法和应用方法
CN108957017A (zh) * 2018-05-29 2018-12-07 郑州左安检测科技有限公司 一种检测苯二氮卓的试纸条及其制备方法和应用方法
WO2020016266A1 (en) 2018-07-17 2020-01-23 Ventana Medical Systems, Inc. Materials and methods for detecting fusion proteins
CN112673258B (zh) 2018-09-13 2025-07-25 文塔纳医疗系统公司 用于检测ntrk融合蛋白的组织化学和细胞化学方法
EP3853214A1 (en) 2018-09-20 2021-07-28 Ventana Medical Systems, Inc. Coumarin-based crosslinking reagents
WO2020072348A1 (en) 2018-10-01 2020-04-09 Ventana Medical Systems, Inc. Methods and systems for predicting response to pd-1 axis directed therapeutics
US12153013B2 (en) 2018-10-12 2024-11-26 Roche Sequencing Solutions, Inc. Detection methods for epitachophoresis workflow automation
WO2020104538A1 (en) 2018-11-20 2020-05-28 Ventana Medical Systems, Inc. Methods and systems for preparing and analyzing cellular samples for morphological characteristics and biomarker expression
EP3921648A1 (en) 2019-02-05 2021-12-15 Ventana Medical Systems, Inc. Methods and systems for evaluation of immune cell infiltrate in stage iv colorectal cancer
US20220325268A1 (en) 2019-05-14 2022-10-13 Roche Sequencing Solutions, Inc Devices and methods for sample analysis
EP4021909A4 (en) 2019-08-29 2023-08-30 David C. Martin Biofunctional thiophene monomers
JP2023524568A (ja) 2020-05-07 2023-06-12 ヴェンタナ メディカル システムズ, インク. 腫瘍試料中のegfrおよびegfrリガンドの発現を評価するための組織化学的システムおよび方法
WO2022043491A2 (en) * 2020-08-28 2022-03-03 Ventana Medical Systems, Inc. Conjugates including a detectable moiety
CN116323670A (zh) 2020-09-22 2023-06-23 豪夫迈·罗氏有限公司 对α-1,6-核心-岩藻糖基化的PSA及其岩藻糖基化片段具有特异性的抗体
CN113552362B (zh) * 2021-07-23 2024-08-09 湖北百奥斯生物科技有限公司 一种新型信号放大的免疫荧光试剂盒
WO2023058624A1 (ja) * 2021-10-08 2023-04-13 コニカミノルタ株式会社 染色方法、評価方法および標本
CN116444424B (zh) * 2023-06-16 2023-09-08 广东省大湾区华南理工大学聚集诱导发光高等研究院 一种基于聚集诱导发光的酪酰胺荧光材料、免疫组化染色试剂盒及其应用
WO2025014787A1 (en) 2023-07-07 2025-01-16 Ventana Medical Systems, Inc. Brightfield triplex immunohistochemistry assay for evaluating the colocalization of the er, pr, and ki-67 biomarkers in cells

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2320387A1 (de) * 1973-04-21 1974-10-31 Boehringer Mannheim Gmbh Phenoxyalkylcarbonsaeurederivate und verfahren zur herstellung derselben
US4469797A (en) 1982-09-23 1984-09-04 Miles Laboratories, Inc. Digoxigenin immunogens, antibodies, labeled conjugates, and related derivatives
JPH01503303A (ja) * 1987-05-19 1989-11-09 フアイソンズ・ピーエルシー 化合物
DE3836656A1 (de) 1988-10-27 1990-05-03 Boehringer Mannheim Gmbh Neue digoxigenin-derivate und ihre verwendung
US5455143A (en) * 1991-10-25 1995-10-03 Minnesota Mining And Manufacturing Company Aminoketone sensitizers for aqueous soluble photopolymer compositions
PT1589107E (pt) 1992-08-21 2010-03-29 Univ Bruxelles Imunoglobulinas desprovidas de cadeias leves
US6005079A (en) 1992-08-21 1999-12-21 Vrije Universiteit Brussels Immunoglobulins devoid of light chains
EP0933355A1 (en) * 1997-12-24 1999-08-04 Universiteit Maastricht Preparation of tyramide conjugates
US6437146B1 (en) * 1998-09-25 2002-08-20 Fujisawa Pharmaceutical Co., Ltd. Oxazole compounds as prostaglandin e2 agonists or antagonists
US6372937B1 (en) 1998-11-09 2002-04-16 Mark Norman Bobrow Enhanced catalyzed reporter deposition
US6387900B1 (en) * 1999-08-12 2002-05-14 Pharmacia & Upjohn S.P.A. 3(5)-ureido-pyrazole derivatives process for their preparation and their use as antitumor agents
EP1212314B1 (en) * 1999-09-17 2005-11-30 Nissan Chemical Industries, Ltd. Benzopyran derivative
US6630469B2 (en) * 2000-05-09 2003-10-07 Bristol-Myers Squibb Company 5-HT7 receptor antagonists
AU2001264694B8 (en) * 2000-05-19 2006-05-04 Laboratoires Serono Sa Use of pyrazole derivatives for treating infertility
US6649138B2 (en) 2000-10-13 2003-11-18 Quantum Dot Corporation Surface-modified semiconductive and metallic nanoparticles having enhanced dispersibility in aqueous media
US20020083888A1 (en) 2000-12-28 2002-07-04 Zehnder Donald A. Flow synthesis of quantum dot nanocrystals
EP2218762A3 (en) 2001-07-20 2010-09-29 Life Technologies Corporation Luminescent nanoparticles and methods for their preparation
US20050101657A1 (en) * 2001-12-28 2005-05-12 Takeda Chemical Industries Ltd. Androgen receptor antagonists
WO2005001889A2 (en) 2003-05-07 2005-01-06 Indiana University Research & Technology Corporation Alloyed semiconductor quantum dots and concentration-gradient alloyed quantum dots, series comprising the same and methods related thereto
EP1651595A2 (en) * 2003-05-30 2006-05-03 Rigel Pharmaceuticals, Inc. Ubiquitin ligase inhibitors
JP4411153B2 (ja) * 2003-07-18 2010-02-10 富士フイルム株式会社 2光子吸収色素消色材料、3次元的屈折率変調材料、3次元吸収率変調材料及び3次元光記録材料
KR100657891B1 (ko) 2003-07-19 2006-12-14 삼성전자주식회사 반도체 나노결정 및 그 제조방법
DE10348022A1 (de) * 2003-10-15 2005-05-25 Imtm Gmbh Neue Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen
GB0324551D0 (en) * 2003-10-21 2003-11-26 Karobio Ab Novel compounds
EP1682547B1 (en) * 2003-10-30 2012-10-24 Boehringer Ingelheim (Canada) Ltd. Rsv polymerase inhibitors
TW200533357A (en) * 2004-01-08 2005-10-16 Millennium Pharm Inc 2-(amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases
US20060246423A1 (en) 2005-02-10 2006-11-02 Adelson Martin E Method and kit for the collection and maintenance of the detectability of a plurality of microbiological species in a single gynecological sample
JP2008541015A (ja) 2005-04-28 2008-11-20 ベンタナ・メデイカル・システムズ・インコーポレーテツド ナノ粒子コンジュゲート
WO2007062177A2 (en) 2005-11-23 2007-05-31 Ventana Medical Systems, Inc. Molecular conjugate
CA3069091C (en) * 2006-11-01 2021-09-14 Ventana Medical Systems, Inc. Haptens, hapten conjugates, compositions thereof and method for their preparation and use
JP2008228637A (ja) * 2007-03-20 2008-10-02 Tokushima Bunri Univ 蛍光相関分光測定法を用いた過酸化水素量の測定方法及びその利用方法
US20080299555A1 (en) * 2007-05-30 2008-12-04 Hiroaki Nitta Multicolor chromogenic detection of biomarkers
CN102438988B (zh) * 2009-04-21 2015-06-24 内尔维阿诺医学科学有限公司 作为hsp90抑制剂的间苯二酚衍生物
US9291597B2 (en) * 2010-07-02 2016-03-22 Ventana Medical Systems, Inc. Detecting targets using mass tags and mass spectrometry

Similar Documents

Publication Publication Date Title
JP2013531801A5 (cg-RX-API-DMAC7.html)
WO2009021031A3 (en) Proximity ligation assay
JP2010254993A5 (cg-RX-API-DMAC7.html)
MX2008014293A (es) Metodos de ensayo sin separacion.
WO2009070640A3 (en) Methods and compositions for amplifying a detectable signal
Gupta et al. Copper promoted N-alkylation of sulfoximines with alkylboronic acid under mild conditions
WO2012003476A3 (en) Hapten conjugates for target detection
JP2010539456A5 (cg-RX-API-DMAC7.html)
NO20080249L (no) Transglutaminaseformidlet konjugasjon av veksthormon
US20100273189A1 (en) Non separation assays with selective signal inhibitors
JP2015529208A5 (cg-RX-API-DMAC7.html)
NO20076462L (no) Fremgangsmate for framstilling av sulfamidderivater
EA033468B1 (ru) Способы получения конъюгата "антитело-майтансиноид"
EP2444807A3 (en) Haptens, hapten conjugates, compositions thereof and method for their preparation and use
WO2004042030A3 (en) Displacement sandwich immuno-pcr
WO2007109129A3 (en) Methods for preparing complex multivalent immunogenic conjugates
JP2015529197A5 (cg-RX-API-DMAC7.html)
JP2019532275A5 (cg-RX-API-DMAC7.html)
WO2022223783A8 (en) Thiol-conjugation with unsaturated phosphorus(v) compounds
JP2020500186A5 (cg-RX-API-DMAC7.html)
JP2015508500A5 (cg-RX-API-DMAC7.html)
Ábrányi-Balogh et al. Warheads for designing covalent inhibitors and chemical probes
EA200800756A1 (ru) СПОСОБ ПОЛУЧЕНИЯ ПОЛИМЕРНЫХ КОНЪЮГАТОВ ДОКСОРУБИЦИНА С КОНТРОЛИРУЕМЫМ pH ВЫСВОБОЖДЕНИЕМ ЛЕКАРСТВЕННОГО СРЕДСТВА
DK2189539T3 (da) Konjugatkomplekser til analytdetektering
WO2006102722A8 (en) Process for the production of ϝ-glutamylcysteine